Health and diagnostics company, owner of the IM8 supplement brand.
3 AI-extracted insights from 3 sources — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about Prenetics Global Limited in the last 30 days yet.
The 3 sources with the most insights about Prenetics Global Limited on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Benefiting from growing consumer health and longevity trends, with potential upside if tokenized stock trading and RWA pairings expand.
Successfully executed a strategic turnaround from post-COVID diagnostic testing into the DTC health space with its IM8 brand, reaching a $200 million annual revenue run rate with declining customer acquisition costs.
Rapid growth of IM8 brand to $100M ARR suggests potential undervaluation relative to market cap.
Benefiting from growing consumer health and longevity trends, with potential upside if tokenized stock trading and RWA pairings expand.
Successfully executed a strategic turnaround from post-COVID diagnostic testing into the DTC health space with its IM8 brand, reaching a $200 million annual revenue run rate with declining customer acquisition costs.
Rapid growth of IM8 brand to $100M ARR suggests potential undervaluation relative to market cap.
Other assets that creators frequently mention in the same content as Prenetics Global Limited.
The most active sources covering Prenetics Global Limited (PRE) on Kazuha are @myfirstmillionpod, John Coogan & Jordi Hays, Steady Lads. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 3 AI-extracted insights about Prenetics Global Limited (PRE) from 3 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Prenetics Global Limited (PRE) most frequently also discuss HYPE, CMCSA, IRM, PANW, MSFT. See the "Discussed alongside" section above for full asset pages.